1.A case of Bm.
Heung Bum OH ; Kyou Sup HAN ; Byoung Kook KIM ; Bok Yun HAN ; Han Ik CHO
Korean Journal of Blood Transfusion 1993;4(1):97-101
No abstract available.
2.CT and MR findings of primitive neuroectodermal tumor.
Shin Ho KOOK ; In One KIM ; Kee Hyun CHANG ; Moon Hee HAN ; Byung Kyu CHO
Journal of the Korean Radiological Society 1991;27(4):503-508
No abstract available.
Neuroectodermal Tumors, Primitive*
3.Analysis of routine test results for the diagnosis of paraxysmal nocturnal hemoglobinuria.
Sun Hee KIM ; Sung Sup PARK ; Chong Hyun YOON ; Han Ik CHO ; Byoung Kook KIM
Korean Journal of Clinical Pathology 1993;13(2):225-231
No abstract available.
Diagnosis*
;
Hemoglobinuria*
4.Clinical observation for the treatment of talus fracture.
Dong Bae SHIN ; Han Ji JUNG ; Phil Gu YI ; Jong Soon KIM ; Byung Kook CHO
The Journal of the Korean Orthopaedic Association 1993;28(1):291-299
No abstract available.
Talus*
5.A case of blastic relapse after allogeneic bone marrow transplantation for chronic myelogenous leukemia in chronic phase.
Heung Bum OH ; Sung Sup PARK ; Byoung Kook KIM ; Hyoun Chan CHO ; Han Ik CHO ; Sang In KIM
Korean Journal of Hematology 1993;28(2):413-419
No abstract available.
Bone Marrow Transplantation*
;
Bone Marrow*
;
Leukemia, Myelogenous, Chronic, BCR-ABL Positive*
;
Recurrence*
6.Histological classification of chronic myelogenous leukemia : clinicopathologic correlation and prognostic significance.
Nam Yong LEE ; Sung Sup PARK ; Han Ik CHO ; Sang In KIM ; Byoung Kook KIM ; Seon Yang PARK ; Heon KIM
Korean Journal of Clinical Pathology 1993;13(2):197-209
No abstract available.
Classification*
;
Leukemia, Myelogenous, Chronic, BCR-ABL Positive*
7.Sequential changes of bone marrow pathology and BFU-E in recipients of allogenic bone marrow transplantation.
Jong Hyun YOON ; Han Ik CHO ; Sang In KIM ; Byeong Kook KIM ; Seonyang PARK ; Noe Kyeong KIM ; Munho LEE
Korean Journal of Hematology 1992;27(1):23-32
No abstract available.
Bone Marrow Transplantation*
;
Bone Marrow*
;
Erythroid Precursor Cells*
;
Pathology*
8.Clinical and laboratory characterization of hybrid leukemias.
Seonyang PARK ; Je Hwan LEE ; Sung Hyun YANG ; Myoung Hee PARK ; Nyeong Kook KIM ; Han Ik CHO ; Noe Kyeong KIM
Korean Journal of Hematology 1992;27(2):261-272
No abstract available.
Leukemia*
9.Four cases of therapy-related leukemia.
Mina HUR ; Dong Soon LEE ; Hee Young SHIN ; Hyo Seop AHN ; Byoung Kook KIM ; Han Ik CHO
Journal of Korean Medical Science 1999;14(3):327-329
Combination chemotherapy and radiation therapy have contributed to the successful treatment of various cancer patients. But the development of second malignancies is an inevitable complication of long-term cytotoxic treatment. The most serious and frequent of such complications is acute myelogenous leukemia (AML). Therapy-related leukemia is generally fatal. Since the number of patients exposed to chemotherapy is increasing each year, the clinical significance of this entity cannot be underestimated. There have been many investigations of therapy-related leukemia, but in Korea published reports are rare. We describe four such cases, involving one older female with lung cancer and three children with acute lymphoblastic leukemia (ALL) and malignant lymphoma. Alkylating agents were used for chemotherapy, and in one case, topoisomerase II inhibitor. Irrespective of the causative agents, the latency periods were relatively short, and despite induction chemotherapy in two, all survived for only a few months. During the follow-up of patients treated for primary malignancies, the possibility of therapy-related leukemia should always be borne in mind.
Adolescence
;
Aged
;
Antineoplastic Agents, Alkylating/therapeutic use*
;
Antineoplastic Agents, Alkylating/adverse effects
;
Carcinoma, Small Cell/radiotherapy
;
Carcinoma, Small Cell/drug therapy
;
Case Report
;
Child
;
DNA Topoisomerase (ATP-Hydrolysing)/antagonists & inhibitors
;
Fatal Outcome
;
Female
;
Human
;
Leukemia, Lymphocytic, Acute, L1/drug therapy
;
Leukemia, Monocytic, Acute/etiology
;
Leukemia, Myelocytic, Acute/etiology*
;
Leukemia, Myelomonocytic, Acute/etiology*
;
Lung Neoplasms/radiotherapy
;
Lung Neoplasms/drug therapy
;
Lymphoma, B-Cell/radiotherapy
;
Lymphoma, B-Cell/drug therapy
;
Male
;
Neoplasms, Second Primary/etiology*
10.Traumatic Epidural Hematoma of the Posterior Cranial Fossa.
Jungin HAN ; Tack Geun CHO ; Jae Gon MOON ; Ho Kook LEE ; Chang Hyun KIM
Korean Journal of Neurotrauma 2012;8(2):99-103
OBJECTIVE: Epidural hematoma of posterior fossa is less common than epidural hematoma of supratentorial area, and there are not many articles about epidural hematoma of posterior fossa. This study investigated patients who underwent surgery of epidural hematoma of posterior fossa, and the relation between the clinical manifestation and postoperative outcome. METHODS: A retrospective analysis performed of 27 patients who underwent operation for acute traumatic epidural hematoma of posterior fossa from January 2004 to December 2011. Analyzed factors were gender, age, Glasgow Coma Scale (GCS) measured upon presentation to the hospital, preoperative GCS score, cause of trauma, time elapsed from the accident to the presentation to the hospital, time elapsed from the presentation to the hospital to the surgery, radiographic findings (brain CT findings), and Glasgow Outcome Scale (GOS). RESULTS: Two patients (7.4%) had GCS score on admission of 3-8, 11 (29.6%) had 9-12, and 17 (66.7%) had 13-15. In 1 (3.7%) patient, GCS score changed from 13 to 10, and preoperative GCS score was significantly correlated with GOS score (p<0.05). Mean thickness of hematoma was 19.3+/-7.5 mm, and was significantly correlated with GOS score (p<0.05). GOS score was 4-5 in 24 patients (88.9%), 3 (severe disability) in 1 patient (3.7%), and 1 (death) in 2 patients (7.4%). CONCLUSION: In the patients underwent surgery for epidural hematoma of posterior fossa, 88.9% had favorable outcome (in GOS score of 4 or more). Preoperative GCS score and thickness of hematoma on brain computed tomography are important determinants of prognosis.
Brain
;
Cranial Fossa, Posterior
;
Glasgow Coma Scale
;
Glasgow Outcome Scale
;
Hematoma
;
Humans
;
Prognosis
;
Retrospective Studies